PubRank

Angela Brooks-Wilson

Author PubWeight™ 88.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Genome sequence of the SARS-associated coronavirus. Science 2003 16.68
2 Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011 9.71
3 Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010 4.51
4 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
5 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006 4.13
6 A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010 3.86
7 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
8 Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 2010 2.86
9 Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet 2009 2.73
10 Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010 2.37
11 The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res 2011 2.09
12 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
13 Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population. Pharmacogenomics 2009 1.55
14 High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood 2008 1.55
15 Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013 1.36
16 Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood 2008 1.36
17 CGMIM: automated text-mining of Online Mendelian Inheritance in Man (OMIM) to identify genetically-associated cancers and candidate genes. BMC Bioinformatics 2005 1.27
18 Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One 2011 1.20
19 A survey of genomic properties for the detection of regulatory polymorphisms. PLoS Comput Biol 2007 1.14
20 The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One 2012 1.12
21 Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination. Cancer Causes Control 2009 1.07
22 Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome. J Gerontol A Biol Sci Med Sci 2007 1.07
23 Comparison of two diverse populations, British Columbia, Canada, and Ardabil, Iran, indicates several variables associated with gastric and esophageal cancer survival. J Gastrointest Cancer 2011 0.99
24 Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 2013 0.99
25 Reduced telomere length variation in healthy oldest old. Mech Ageing Dev 2008 0.97
26 Cost-effective prediction of gender-labeling errors and estimation of gender-labeling error rates in candidate-gene association studies. Front Genet 2011 0.92
27 Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol 2015 0.91
28 Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res 2013 0.89
29 Shift work, circadian gene variants and risk of breast cancer. Cancer Epidemiol 2013 0.89
30 CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure. Haematologica 2009 0.89
31 PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood 2012 0.89
32 Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction. PLoS One 2013 0.86
33 Estimates of array and pool-construction variance for planning efficient DNA-pooling genome wide association studies. BMC Med Genomics 2011 0.84
34 The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada. BMC Cancer 2011 0.81
35 Fasting insulin and endogenous hormones in relation to premenopausal breast density (Canada). Cancer Causes Control 2014 0.81
36 Absence of NR2E1 mutations in patients with aniridia. Mol Vis 2012 0.80
37 Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes. Leuk Res 2011 0.79
38 Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. PLoS One 2011 0.78
39 Identifying related cancer types based on their incidence among people with multiple cancers. Emerg Themes Epidemiol 2006 0.78
40 Occupational exposure and ovarian cancer risk. Cancer Causes Control 2014 0.77
41 Shared genetic factors for age at natural menopause in Iranian and European women. Hum Reprod 2013 0.77
42 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77
43 Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2015 0.75